OEM Cosmetic Manufacturing for Scalable Beauty Brands

OEM cosmetic manufacturing at NEXO Beauty Labs covers beauty products across skincare, hair care and body care for brand owners who need a production partner rather than a catalogue. This page sets out the development routes, the inputs a quotation depends on, and the responsibilities that stay with the brand.

Request a Line Quotation Compare Manufacturing Routes

Cosmetic manufacturing laboratory and scalable production line view

Three routes.

Your formula, our development, or a full-service turnkey project.

Two decisions first.

Who owns the formula, and who carries the market-facing legal role.

One brief.

Everything a usable quotation request contains is in the readiness matrix below.

Manufacturing Experience Behind This Line

NEXO Beauty Labs is a global cosmetic OEM and ODM partner working across skincare, hair care, and body care. This line is built on more than 25 years of cosmetic manufacturing expertise. Our manufacturing foundation dates back to 1999.

NEXO Beauty Labs cosmetic manufacturing experience and background

Manufacturing Background in Brief

Manufacturing foundation Dates back to 1999

Category experience More than 25 years of cosmetic manufacturing expertise

Export-facing team Operating since 2020

Categories in scope Skincare, hair care, body care

Partner model Cosmetic OEM and ODM

Project span Concept to commercial production

That foundation carries extensive experience in formulation development, production management, and quality control. NEXO combines professional research and development capabilities with manufacturing systems and market insight from the beauty market we supply. We specialize in skin care, hair care and body care rather than every cosmetic format.

Who this line is built for. Our international business team has worked with global beauty brands since 2020. Those partners include brands, e-commerce companies, distributors, and private label partners in different regions. NEXO connects them with cosmetic development and manufacturing solutions from concept through commercial production.

Experience does not transfer market-facing duties: for United States sales, FDA assigns facility registration and product listing to defined actors.1

Start Your Cosmetic Project

Development Routes: OEM, ODM and Turnkey

Quoting delay most often derives from an unstated route. Buyers arriving with a completed formula are posing a different question than buyers arriving with a positioning statement, and those two projects price and schedule differently from day one.

Nexo Beauty Labs Manufacturing Experience Behind This Line

Route comparison: what changes between OEM, ODM and full-service turnkey projects

Decision input	OEM route	ODM route	Turnkey route
Formula origin	Supplied by the brand or its own chemist	Developed against your brief by our research and development team	Selected from a development direction agreed at kickoff, then adjusted
Development starting point	Written formula, batch record or benchmark sample	Target texture, claim direction and cost position	Category, market and launch window
Packaging responsibility	Brand nominates the supplier and component set	Shared: brand approves, we confirm fill and compatibility	Handled as one scope with the formula, including custom packaging
Sample stage focus	Reproducing your reference on our equipment	Converging on texture, scent and stability targets	Confirming the whole product line at once, not one unit
Change control	Changes come from your side and are re-costed	Iterations are planned into the development stage	Changes ripple across formula, component and artwork at once
Documentation ownership	Brand holds the formulation record it supplied	Written before development starts, never assumed	Written before development starts, never assumed
Strongest fit	Established brands moving a proven formula to new capacity	New brand that knows its buyer but not its formula	Distributors and retail partners who need turnkey solutions and speed to market
Main risk to manage	Raw material and equipment differences between sites	Scope creep during iteration rounds	One late decision holds the whole product line

Formula Ownership & Regulatory
Project Route Assessment

Formula ownership must be defined before development fees are paid, because it is not automatic in any of these routes. It is a contract term, settled in writing before development work starts, and the one that most often surprises first-time brand owners. Every route carries a trade-off: OEM gives the brand more formula control but requires a more complete technical package, while turnkey shifts more development work to the manufacturing partner.

The route label does not decide United States regulatory roles; facility registration and responsible-person product listing remain separate FDA duties.1

Not sure which column describes your project? Route questions run in the browser and nothing is sent anywhere.

Open the Route Fit Questions

Product Families in Scope

NEXO operates within three cosmetic product families, with each family exhibiting its own development flow. Each family has its unique bottleneck, and understanding which one applies influences how we should judge the first sample.

Skincare

Emulsions, gels, serums, cleansers and masks within a skincare line.
Stability behaviour under temperature cycling drives the schedule
Active ingredient handling and order of addition are formula-critical
Shelf presentation is influenced equally by the formula and packaging compatibility

Hair Care

Hair care formats including shampoo, conditioner, treatment and styling products.
Viscosity and rinse feel are assessed subjectively, and benchmarks are important
Surfactant system choice sets both cost and claim direction
Fill behaviour differs sharply between bottle and tube components

Body Care

Body care and broader personal care products including lotions, butters, washes and scrubs.
Larger fill volumes alter the unit economics of every raw material choice
Texture expectations shift by target region and season
Scent load interacts with both the base and the component material

In practice, a buyer launching a skincare line alongside a body wash is running two development clocks, not one. One partner covering all three families removes the coordination cost of parallel projects, which is the reason brands consolidate them with NEXO Beauty Labs. It does not remove the technical work, and cross-category scope is not a shortcut through development.

For United States launch planning, each marketed cosmetic product is listed by the responsible person even when several product families share one manufacturing partner.¹

Start Your Cosmetic Project

Development and Manufacturing Capabilities

At NEXO Beauty Labs, our capability set spans the work between a written brief and a released production batch. This scope is backed by more than 25 years of cosmetic manufacturing expertise. Everything below describes what the work covers without promising a fit for a project we have not yet quoted.

Discuss Your Product Idea

Brief interpretation: transforming a positioning statement into a technical target for the formula
Custom formulation and benchmark matching work, or work to customize a product you already sell
Raw material selection and substitution when a nominated ingredient is unavailable regionally
Iteration cycles with written change notes, so texture decisions can be traced directly to the person who requested them

Packaging options considered in relation to fill method, viscosity and component material
Custom packaging coordination when a brand nominates its own supplier
Artwork and decoration managed in relation to files provided by your design team
Compatibility assessments scheduled before locking a component set, rather than after the initial production run

Scale-up from bench batch to production batch, with variation documented
Order quantities and batch sizes verified per formula and per component, not as a single overall amount
Production management and release controls compared to the specifications agreed for the batch
Repeat-order procedures so a second run replicates the approved batch, not a new interpretation

OEM Manufacturing Readiness Matrix

The majority of quotation delays within cosmetic contract manufacturing originate from missing inputs rather than complex technical queries. Six factors influence whether a brief can be priced, and we evaluate these same six factors prior to issuing a quotation.

Six readiness dimensions, the inputs you prepare, and the items confirmed before quotation

Readiness dimension	Prepared by you	Confirmed by us before quotation
Product category	Category, format and the closest benchmark product you can name	Whether the format sits inside our skincare, hair care and body care scope
Development ownership	Whether you bring a formula, a brief, or only a market position	The route, the iteration model and where your chemist sits in the loop
Formula status	Formulation record, ingredient restrictions and any banned-list constraints	Raw material availability and whether a substitution changes the claim
Packaging status	Component decision, nominated supplier and artwork readiness	Fill compatibility, decoration feasibility and component lead dependencies
Market and claims	Target markets, intended use, claim wording and label language	Which legal role each side carries in that market, in writing1
Commercial expectations	Volume band, budget position and the launch date you are working back from	Minimum order quantities per formula and per component, and the schedule they imply

A specification that provides answers to all six can be quoted against. A specification that only provides answers to three sends the project into a Q&A pit that uses more calendar time than the development work itself. A laboratory sample is not enough, which is why the sixth dimension asks for the volume band before anyone signs off on a texture.

Score your own brief against the six dimensions before you send it.

Open the Readiness Self-Assessment

Cost Drivers and Schedule Drivers

We do not publish unit prices or turnaround figures here, because both are set by the specification rather than by the category. Order-quantity fit cannot be compared without route-specific information, so this section shows which decisions move the number.

Raw material variation: active concentration and grade change are more costly than fill volume in most skincare formats.
Component set: a custom component, decoration step, or secondary carton each adds cost regardless of the formula.
Batch size in relation to order quantities: one formula costs more at a trial batch than at a repeat production batch.
Claim support work: testing and paperwork requested for a claim are project costs, not overheads absorbed into the unit price.

Iteration cycles: each approval of a sample delays project completion by calendar time, and it is this figure that buyers most underestimate.
Component availability: a specified component on its own manufacturing timetable sets the earliest feasible date for the entire project.
Stability and compatibility work: this runs on its own clock and cannot be accelerated by adding more people.
Artwork and label sign-off: regulatory label content for a target market is often the final deliverable to close.

Quality Control and Market Responsibilities

Quality control inside a factory and legal responsibility in a target market are two separate systems. Target-market paperwork cannot be reduced to a manufacturer badge, and brand owners are frequently told the first system covers the second when it does not. Registration is a record that an actor exists, and it is not interchangeable with product approval on a customs form.

Our release position on the floor is deliberately unromantic: a batch ships against written acceptance criteria for that product, never against anyone’s memory of how the approved sample looked. Where a criterion was never written down, we say so before the batch is filled rather than after.

Which side carries each of those roles is a contract question for your target markets, settled in writing per jurisdiction. Because a manufacturing contract is not a substitute for a statutory duty, NEXO Beauty Labs keeps production release evidence and market responsibility in separate records, which is what closes the documentation gap before a border check finds it.

Work out which market and legal-role inputs your brief is still missing.

From Brief to Commercial Production

This sequence is the working shape of a cosmetic contract manufacturing project. Stage names differ between suppliers; the decision points do not.

01
Brief and route

Category, benchmark, volume band and target markets are captured, and the OEM, ODM or turnkey route is fixed.
02
Terms before development

Formula ownership, confidentiality and documentation handling are agreed in writing before development work begins.
03
Formulation and sampling

Development runs against the technical target, with iteration rounds and written change notes at each pass.
04
Component and artwork lock

Packaging options are confirmed for fill compatibility, then artwork is closed against label content for each market.
05
Scale-up and pilot batch

The approved bench formula is reproduced at production scale and the differences are documented.
06
Production and repeat orders

Release checks run against the approved specification, and the record becomes the reference for the next run.

Manufacturing Partner Evaluation Checklist

Use this section on us as well as on any other cosmetic contract manufacturer you are speaking to. Credibility must be checkable before a brief is shared, and the mistake buyers make is comparing adjectives instead of clauses. The tell is whether a number arrives with a document behind it.

Claims that carry no information

Any world-class label with no test method, audit body or document behind it
Highest quality claims that are not tied to a written specification you can hold
Large round numbers for formulas developed or brands served, with no way to verify either
One certification badge presented as coverage for every product family and every market, which is the clearest red flag on this list

Questions that separate suppliers

Where in your process is formula ownership put in writing, and what happens to it if we stop working together?
Is your minimum order quantity set per formula, per component, or both?
Who holds the market-facing legal role in each country we plan to sell in?1
Can a lab-scale approval be reproduced at production scale, and what changed between them?
What documentation travels with a batch, and what stays with you?

Where This Line Is Not the Right Fit

Scope boundaries are worth stating early. If your project sits in one of the areas below, we are the wrong answer, and a different partner will serve you better than a sampling round that ends in a refusal.

Request a Consultation

Pigment dispersion and pressed formats sit outside the skincare, hair care and body care scope of this line.

Fine fragrance development is a separate discipline from adding a scent to a cosmetic base.

OTC products carry a different regulatory route from cosmetics, and the classification is driven by intended use and claims.

Projects with no production intent are not what a manufacturing partner is built for.

FDA defines that role by the name appearing on the cosmetic label; manufacturing scope alone does not make NEXO that actor.1

OEM Cosmetic Manufacturing Tools

OEM Cosmetic Manufacturing Readiness Self-Assessment

Evaluate your brand’s preparedness for cosmetic manufacturing. Identify operational gaps and align requirements before initiating mass production.

Access Tool

Route Fit Questions: OEM, ODM or Turnkey

Determine the most suitable manufacturing model for your project. Analyze whether OEM, ODM, or Turnkey solutions best support your business goals.

Access Tool

Quotation Brief Builder for Cosmetic Contract Manufacturing

Generate a comprehensive quotation brief for your cosmetic product. Streamline communication with manufacturing partners for precise pricing.

Access Tool

Frequently Asked Questions

Discuss Your Product Idea

OEM cosmetic manufacturing is production carried out by a manufacturer for a brand that owns the product identity. In the strict sense, the brand supplies the formula and the manufacturer reproduces it at scale, making the manufacturer a capacity and process partner rather than a development partner. In practice, the term is also used loosely for private label services and projects where the manufacturer performs the formulation work, so confirm the supplier’s meaning before comparing quotations and again in the contract.

Compare the routes by who originates the formula, who carries the iteration risk, and where packaging responsibility sits. The table above puts those inputs side by side. Naming the route in the first message also makes the quotation process faster.

Include the category, benchmark product, route, volume band, target markets, packaging status, and launch date.

Yes. NEXO works across all three families, and the benefit is coordination rather than a technical shortcut. Each family has its own stability, viscosity, and fill behaviour, so treat a multi-category partner as one point of contact rather than one development cycle.

No. A brand can arrive with a finished formulation, a detailed brief, or only a desired market position. Stating what you already have sets the correct development route and sampling plan.

The brief is checked against the six readiness dimensions, gaps are raised as questions, and the route is confirmed. Ownership and confidentiality terms are settled before development begins. Sampling starts only after those points are clear.

Confirm the terms in writing before development, including what happens to the formulation record if the relationship ends. Ownership does not transfer automatically because a brand paid for development. Ask for the clause rather than verbal reassurance.

Both are confirmed in the quotation against your specification. Order quantities are set per formula and per component, so a project can clear the formula threshold and still be held by a packaging component. The section above lists the other cost drivers.

The schedule is confirmed with the quotation once the specification is fixed. Any date given earlier is an estimate.

Name the countries you will sell in, the intended use, the claims you want to make, and the required label languages. In the United States, registration and listing attach to defined actors and are not product approval. In the European Union, a responsible person is required for a product placed on the market.

An internal approval confirms that a batch meets the specification agreed for it. It is a production control and does not substitute for a statutory obligation in the target market. The two records are kept separately for that reason.

Compare written terms rather than adjectives: ownership clauses, order-quantity structure, documentation handling, scale-up evidence, and who carries the legal role in each market. The evaluation section above lists the questions that produce comparable answers.